Saturday, May 4, 2024     8:00 AM – 11:30 AM ET     Skyline Ballroom W375D

Major Symposium B

Recent Breakthroughs and Emerging Therapeutic Strategies for Chronic Inflammatory and Fibrotic Diseases

Chairs
Thomas A. Wynn, Pfizer
Joanne L. Viney, Seismic Therapeut.

Speakers
Thomas A. Wynn, Pfizer, In pursuit of transformational efficacy for autoimmune, inflammatory, and fibrotic diseases with multi-functional therapeutics
Emma Guttman-Yassky, Icahn Sch. of Med., Mount Sinai, USA, A translational approach to improve therapeutics in atopic dermatitis and beyond
Diandra A. Ellis, Tulane Univ., USA, Chitinase 3-Like-1/BRP-39 regulates extracellular matrix remodeling during allergic fungal asthma
Shelia M. Violette, Q32 Bio, Tissue targeted regulators of complement in disease: rationale and novel strategies
Tania E. Velez, Univ. of Virginia, USA, Expanded GATA3+ T regulatory cells fail to control germinal center responses during pulmonary fibrosis in humans and mice
Qizhi Tang, UCSF, USA, Engineering next-gen Tregs for type 1 diabetes
Joanne L. Viney, Seismic Therapeut., The polypharmacology of dual cell bidirectional (DcB) agonist antibodies for treating autoimmunity